Who is sponsoring NCT05799703?

NCT05799703 is sponsored by Basma Elsaid Mahmoud Bakr.

What drugs are being tested in NCT05799703?

Interventions in NCT05799703: electrical stimulation device, kinesio taping.

What condition does NCT05799703 study?

NCT05799703 studies Cerebral Palsy.

Is NCT05799703 still recruiting?

NCT05799703 is currently completed. Last updated 12 March 2024.

Last reviewed 2024-03-12 · How we verify

NCT05799703

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Reciprocal Electrical Stimulation Versus Kinesio Taping

Completed NA Last updated 12 March 2024

What this trial tests

NA trial testing electrical stimulation device in Cerebral Palsy in 68 participants. Completed in 30 October 2023.

Timeline

15 February 2023

Primary endpoint
15 October 2023

30 October 2023

Quick facts

Lead sponsor	Basma Elsaid Mahmoud Bakr
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	double
Primary purpose	treatment
Enrollment	68
Start date	15 February 2023
Primary completion	15 October 2023
Estimated completion	30 October 2023
Sites	1 location across Egypt

Drugs / interventions tested

electrical stimulation device
kinesio taping

Conditions studied

Cerebral Palsy — all drugs for Cerebral Palsy →

Sponsor

Basma Elsaid Mahmoud Bakr

Who can join

Adults 4 to 6, any sex, with Cerebral Palsy. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study will be conducted to: 1. evaluate the effect of kinesio taping on hand functions in hemiplegic cerebral palsy children 2. compare between the effects of reciprocal electrical stimulation and kinesio taping on hand functions in hemiplegic cerebral palsy children.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Cerebral Palsy

Currently open trials in the same condition.

NCT07524972 — Antenatal Magnesium Sulphate in High-Risk Preterm Patients · Phase 3 · recruiting
NCT07432789 — Metrological Properties of a Digital Motion Analysis Research Application for Assessing the Motor Abilities and Performa · NA · recruiting
NCT07466914 — Constipation in Children With Cerebral Palsy · active not recruiting
NCT05901259 — The EXOPULSE Study - a Database for Routine Follow-up of Clinical Outcomes · recruiting
NCT07342348 — Using Power Mobility Training to Promote Arm & Hand Function in Children With Cerebral Palsy · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT05799703 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Basma Elsaid Mahmoud Bakr
Last refreshed: 12 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05799703.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing